- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: Acute stress reaction.
Displaying page 1 of 1.
EudraCT Number: 2012-001263-73 | Sponsor Protocol Number: 30-01-2012_1 | Start Date*: 2012-05-25 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: Involvement of corticotrophin-releasing hormone (CRH) and mucosal mast cells in stress-induced changes in intestinal permeability in healthy volunteers. | |||||||||||||
Medical condition: Stress-induced intestinal hyperpermeability | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001288-58 | Sponsor Protocol Number: 40122 | Start Date*: 2012-05-21 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: Boosting oxytocin after trauma: The effects of intranasal oxytocin administration on emotional and motivational brain processes in PTSD | |||||||||||||
Medical condition: Posttraumatic Stress Disorder (PTSD) according to criteria in the DSM-IV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005405-78 | Sponsor Protocol Number: 2011430 | Start Date*: 2012-02-01 | ||||||||||||||||
Sponsor Name:Steen Bendix Haugaard | ||||||||||||||||||
Full Title: Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes | ||||||||||||||||||
Medical condition: Patients suffering of both Type 2 diabetes mellitus and coronary artery disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002116-32 | Sponsor Protocol Number: MTM-04 | Start Date*: 2015-09-23 | ||||||||||||||||||||||||||
Sponsor Name:Køge Hospital | ||||||||||||||||||||||||||||
Full Title: The effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep disturbances in patients after acute myocardial syndrome | ||||||||||||||||||||||||||||
Medical condition: Depression Anxiety Sleep disturbances Circadian disturbances | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-001420-34 | Sponsor Protocol Number: 0001 | Start Date*: 2020-04-14 | |||||||||||
Sponsor Name:Aarhus University | |||||||||||||
Full Title: Senicapoc in COVID-19 Patients with Severe Respiratory Insufficiency – A Randomized, Open-Label, Phase II Trial | |||||||||||||
Medical condition: Infection with COVID19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000304-16 | Sponsor Protocol Number: B4Z-UT-S017 | Start Date*: 2021-12-02 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Double-blind Comparison of Atomoxetine Hydrochloride and Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents With Autism Spectrum Disorder. | |||||||||||||
Medical condition: Attention-Deficit/Hyperactivity Disorder | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000991-33 | Sponsor Protocol Number: PI10/02877 | Start Date*: 2012-07-13 |
Sponsor Name:Instituto Aragonés de Ciencias de la Salud | ||
Full Title: Impact of melatonin in the pretreatment of organ donor and the influence in the evolution of liver transplant: a prospective, randomised double-blind study. | ||
Medical condition: Organ Transplant | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001395-15 | Sponsor Protocol Number: Awaiting | Start Date*: 2020-04-06 | ||||||||||||||||
Sponsor Name:Deparment of Intensive Care, Rigshospitalet | ||||||||||||||||||
Full Title: Low dose hydrocortisone in patients with COVID-19 and severe hypoxia – the COVID STEROID trial | ||||||||||||||||||
Medical condition: Adult patients with COVID-19 and severe hypoxia. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003363-25 | Sponsor Protocol Number: NA | Start Date*: 2020-08-18 | ||||||||||||||||
Sponsor Name:Department of Intensive Care, Rigshospitalet | ||||||||||||||||||
Full Title: Higher vs. Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia: the COVID STEROID 2 trial | ||||||||||||||||||
Medical condition: Adult patients with COVID-19 and severe hypoxia. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002663-33 | Sponsor Protocol Number: NUH-ALS-2015-04 | Start Date*: 2018-11-05 | |||||||||||
Sponsor Name:Alloksys Life Sciences BV | |||||||||||||
Full Title: Preventing Oxidative stress induced Ischemic Injury and Systemic Inflammation complications during and after invasive Cardiac surgery with Alkaline Phosphatase (APPIRED III) | |||||||||||||
Medical condition: systemic inflammation as side-effect of heart-lung machine during cardiac surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) NL (Completed) AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003087-40 | Sponsor Protocol Number: PHRC-N-2015 | Start Date*: 2017-01-17 |
Sponsor Name:UHangers | ||
Full Title: Interest of intraveinous iron and tranexamic acid to reduce transfusion in hip fracture patients - HIFIT Study | ||
Medical condition: Hip fracture | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
